LaQuita M. Jones

Cincinnati Children's Hospital Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting AML-associated FLT3 mutations with a type I kinase inhibitor”.

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor

Journal of Clinical Investigation(2020)10.1172/jci127907

N/A

0DataRank · unranked

39 citations

Katelyn Melgar, Lyndsey Bolanos, Kathleen Hueneman, Morgan M. Walker, Jian-kang Jiang +15 more

Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00269

N/A

0DataRank · unranked

6 citations

Chris J. Finocchio, Elizabeth Croll, Gregory J. Tawa, Huixu Li, Li Ma +22 more

IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid Leukemia

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00147

N/A

0DataRank · unranked

6 citations

Chris J. Finocchio, Elizabeth Croll, Gregory J. Tawa, Mingliang Zhang, Jiangong Wang +20 more